Open AccessPembrolizumab-Induced Steven-Johnson Syndrome in an NSCLC Patient: A Case Report
Author(s) -
Shan Su,
Xinxing Hu,
Hongzhong Yang
Publication year - 2022
Publication title -
health
Language(s) - English
Resource type - Journals
eISSN - 1949-5005
pISSN - 1949-4998
DOI - 10.4236/health.2022.141005
Subject(s) - pembrolizumab , medicine , adverse effect , immunotherapy , lung cancer , presentation (obstetrics) , dermatology , cancer , intensive care medicine , surgery